Advertisements



Here"s Why Mid-Cap Growth ETFs Are Hitting New Highs

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

Here"s Why Mid-Cap Growth ETFs Are Hitting New Highs

Mid caps offer the b.....»»

Category: dealsSource: nytSep 14th, 2018

Top-Ranked Growth ETFs Hitting All-Time Highs

InvestorPlace - Stock Market News, Stock Advice & Trading T.....»»

Category: topSource: investorplaceAug 29th, 2018

A Spread of Top-Ranked Growth ETFs Hitting All-Time Highs

We have highlighted a number of Zacks ETF Rank #1 (Strong Buy) growth ETFs that hit all-time highs in the last trading session and have AUM .....»»

Category: smallbizSource: nytAug 28th, 2018

FAANGs Slip to Bear Market: What Lies Ahead for ETFs?

FAANG stocks have lost nearly $1 trillion in value since hitting their respective 52-week highs, more than $300 billion in market value this month and about $575 billion since the start o.....»»

Category: personnelSource: nyt17 hr. 39 min. ago

Tech ETFs Scaling New Highs on Surging FANG Stocks

These ETFs are hitting record highs on soaring FANG stocks. Though looming trade tensions between the United States and some of its key pa.....»»

Category: dealsSource: nytJun 21st, 2018

5 Niche Tech ETFs Hitting All-Time Highs

InvestorPlace - Stock Market News, Stock Advice & Tra.....»»

Category: topSource: investorplaceMay 24th, 2018

5 Market-Beating Small-Cap ETFs Trading at New Highs

The small-cap segment of the broader market has been outperforming hitting new highs, defying extremely volatilit.....»»

Category: personnelSource: nytMay 15th, 2018

The Daily Biotech Pulse: Denali"s Positive Results, Novartis" Substance Abuse Therapy Launch, Medtronic Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 19) read more.....»»

Category: blogSource: benzinga21 hr. 9 min. ago

Novartis Is Set For "Higher Returns And Growth," Goldman Sachs Says In Upgrade

Novartis AG (NYSE: NVS) has been on a tear since hitting a year-over-year nadir in June. As the drugmaker rides positive partnerships, drug approvals and trial successes, one analyst is projecting good health in the near-term.  Latest Ratin.....»»

Category: blogSource: benzingaNov 19th, 2018

The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 15) read more.....»»

Category: blogSource: benzingaNov 16th, 2018

The Daily Biotech Pulse: FDA Nod For Mallinckrodt"s Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 14) read more.....»»

Category: blogSource: benzingaNov 15th, 2018

The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape"s Earnings, Vapotherm To Debut

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 13) read more.....»»

Category: blogSource: benzingaNov 14th, 2018

Why oil went from 4-year highs to bear market in just 6 weeks

The oil market is undergoing a stunning reversal as crude futures wipe out this year's gains after hitting their highest levels since 2014 just six weeks ago......»»

Category: topSource: moneycentralNov 13th, 2018

Small business optimism dips slightly, remains in record territory

Small business optimism is slowly retreating from all-time highs posted in August, but the National Federation of Independent Business sees continued economic and employment growth through the end of the year......»»

Category: topSource: moneycentralNov 13th, 2018

October Small Business Optimism Dips Slightly, Remains in Record Territory

Small business optimism is slowly retreating from all-time highs posted in August, but the National Federation of Independent Business sees continued economic and employment growth through the end of........»»

Category: blogSource: 247wallstNov 13th, 2018

The Daily Biotech Pulse: Viking"s Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton"s Debut

Here's a roundup of top developments in the biotech space over the last 24 hours. None of the Nasdaq-listed biotech stocks hit 52-week highs Nov. 12. Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 12) read more.....»»

Category: blogSource: benzingaNov 13th, 2018

"King dollar" reigns supreme in world of slowing growth, European risks

The dollar surged to nearly 17-month highs on Monday against a basket of major currencies as investors sought out the liquid and high-yielding asset against a backdrop of global growth worries and rising political risk in Italy and Britain......»»

Category: topSource: reutersNov 12th, 2018

"King dollar" benefits from European risks, growth fears

The dollar surged to nearly 17-month highs on Monday against a basket of major currencies as investors sought out the highly liquid and high-yielding currency against a backdrop of global growth worry and rising political risk in Italy and Britain......»»

Category: topSource: reutersNov 12th, 2018

5 Top-Ranked Growth ETFs & Stocks to Tap Post Mid-Term Rally

InvestorPlace - Stock Market News.....»»

Category: topSource: investorplaceNov 10th, 2018

Beat the Market with Pure Style ETFs

Pure style ETFs offer focused exposure to stocks with strong growth and value character.....»»

Category: worldSource: nytNov 9th, 2018